Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Tel Aviv
  • Sector: Financials
  • Industry: Asset Management
  • Sub-Industry: Investment Companies

Bio Light Israeli Life Sciences Investments Ltd

+ Add to Watchlist


19.00 ILs 0.000.00%

As of 04:02:02 ET on 05/04/2015.

Snapshot for Bio Light Israeli Life Sciences Investments Ltd (BOLT)

Open: 19.00 Day's Range: 19.00 - 19.10 Volume: 35,942
Previous Close: 19.00 52wk Range: 13.10 - 20.40 1-Yr Rtn: 0.00%

Stock Chart for BOLT

No chart data available.
  • BOLT:IT 19.00
  • 1D
  • 1M
  • 1Y
Interactive BOLT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BOLT

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. TA-100 -
Earnings Per Share (ILS) (ttm) -0.0510
Est. EPS (ILS) (12/2015) -0.0400
Est. PEG Ratio -
Market Cap (M ILS) 99.58
Shares Outstanding (M) 521.34
30 Day Average Volume 2,066,670
Price/Book (mrq) 3.0029
Price/Sale (ttm) 104.1612
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BOLT

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for BOLT

Bio Light Israeli Life Sciences Investments Ltd. is a holding company. The Company through subsidiary companies develops a drug for weight management, and another drug for blocking allergies. The Company developed laser based non-invasive technology for the treatment of Glaucoma, and is developing diagnostic kits for surgical cancer procedures and cancer drugs.

Suzana Nahum ZilberbergChief Executive OfficerItai Bar-NatanChief Financial Officer
More Company Profile & Key Executives for BOLT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil